Literature DB >> 3338507

Occurrence of multiple antibiotic resistance and R plasmids in Enterobacteriaceae isolated from children in the Sudan.

P Shears1, G Suliman, C A Hart.   

Abstract

The prevalence of resistance to six commonly-used antimicrobial agents in faecal coliforms from children in Khartoum, Sudan was studied. A relatively high prevalence of resistance was found, ranging from 96% of children with isolates resistant to ampicillin to 70% of children with isolates resistant to chloramphenicol. Seventy-seven percent of children had isolates with high-level resistance to trimethoprim (MIC greater than 1000 micrograms/ml). Twenty-nine different resistance patterns were found. Thirty-nine percent of the children had isolates resistant to all six antibiotics studied, and 80% of children had isolates resistant to at least four. Transfer of resistance to each of the antimicrobials, in varying combinations, was demonstrated, but did not occur for all resistance patterns. Plasmid analysis showed plasmids ranging from 160 MDa to 2.8 MDa and isolates contained from one to five plasmids of different sizes. There were no consistent relationships between resistance pattern and plasmid profile, but multiple resistance transfer was mediated commonly by plasmids with a molecular weight of 62 MDa. The high prevalence of potentially transferable antibiotic resistance in gut commensals of children in the Sudan may be of importance in the management of enteric and other infections requiring antimicrobial treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3338507      PMCID: PMC2249195          DOI: 10.1017/s0950268800065572

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  18 in total

1.  A note on antibiotic resistance in Escherichia coli isolated from children with diarrhoea in the Sudan.

Authors:  P Shears; C A Hart; R L Broadhead; J B Coulter
Journal:  Ann Trop Paediatr       Date:  1987-03

Review 2.  Antibiotic resistance in developing countries.

Authors:  W E Farrar
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

3.  Self-prescribing by way of pharmacies in three Asian developing countries.

Authors:  G Tomson; G Sterky
Journal:  Lancet       Date:  1986-09-13       Impact factor: 79.321

4.  Trimethoprim resistance amongst urinary pathogens in south India.

Authors:  H K Young; M V Jesudason; G Koshi; S G Amyes
Journal:  J Antimicrob Chemother       Date:  1986-05       Impact factor: 5.790

5.  Acute lymphoblastic leukaemia: trimethoprim resistant organisms during treatment.

Authors:  H P McDowell; P Shears; C A Hart; J Martin
Journal:  Arch Dis Child       Date:  1987-06       Impact factor: 3.791

6.  Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries.

Authors:  B E Murray; T Alvarado; K H Kim; M Vorachit; P Jayanetra; M M Levine; I Prenzel; M Fling; L Elwell; G H McCracken
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

7.  Sensitivity of Salmonella and Shigella to antibiotics and chemotherapeutic agents in Sudan.

Authors:  H S Hassan
Journal:  J Trop Med Hyg       Date:  1985-08

8.  Resistance to antibiotics at medical centres in different parts of the world.

Authors:  T F O'Brien
Journal:  J Antimicrob Chemother       Date:  1986-10       Impact factor: 5.790

9.  Antibiotic resistance and conjugative R plasmids in clinical isolates of Enterobacteriaceae in Peninsular Malaysia.

Authors:  C L Koh
Journal:  Trans R Soc Trop Med Hyg       Date:  1986       Impact factor: 2.184

10.  A note on antibiotic-resistant Escherichia coli in adult man, raw sewage and sewage-polluted River Tigris in Mosul, Nineva.

Authors:  M M Al-Jebouri; N S Al-Meshhadani
Journal:  J Appl Bacteriol       Date:  1985-12
View more
  10 in total

Review 1.  The human gut mobile metagenome: a metazoan perspective.

Authors:  Brian V Jones
Journal:  Gut Microbes       Date:  2010 Nov-Dec

2.  Beta-lactam resistance in normal faecal flora from South Africa.

Authors:  P M Shanahan; C J Thomson; S G Amyes
Journal:  Epidemiol Infect       Date:  1995-10       Impact factor: 2.451

3.  The prevalence and genetics of resistance to commonly used antimicrobial agents in faecal Enterobacteriaceae from children in Bangladesh.

Authors:  K Z Mamun; P Shears; C A Hart
Journal:  Epidemiol Infect       Date:  1993-06       Impact factor: 2.451

4.  Restriction endonuclease characterization of resistant plasmids in Enterobacteriaceae isolated from children in the Sudan.

Authors:  P Shears; G Suliman; C A Hart
Journal:  Epidemiol Infect       Date:  1989-12       Impact factor: 2.451

5.  Antimicrobial resistance in fecal flora: longitudinal community-based surveillance of children from urban Mexico.

Authors:  J J Calva; J Sifuentes-Osornio; C Cerón
Journal:  Antimicrob Agents Chemother       Date:  1996-07       Impact factor: 5.191

6.  The prevalence of antibiotic-resistant faecal Escherichia coli in healthy volunteers in Venezuela.

Authors:  H J van de Mortel; E J Jansen; G J Dinant; N London; E Palacios Prü; E E Stobberingh
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

7.  Trimethoprim resistant dihydrofolate reductases in normal faecal flora isolated in India.

Authors:  S Tait; S G Amyes
Journal:  Epidemiol Infect       Date:  1994-10       Impact factor: 2.451

8.  In vitro activity of florphenicol.

Authors:  R Graham; D Palmer; B C Pratt; C A Hart
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-10       Impact factor: 3.267

9.  High prevalence of multidrug resistance in bacterial uropathogens from Kathmandu, Nepal.

Authors:  Pankaj Baral; Sanjiv Neupane; Bishnu Prasad Marasini; Kashi Ram Ghimire; Binod Lekhak; Basudha Shrestha
Journal:  BMC Res Notes       Date:  2012-01-19

Review 10.  Evolutionary, ecological and biotechnological perspectives on plasmids resident in the human gut mobile metagenome.

Authors:  Lesley A Ogilvie; Sepinoud Firouzmand; Brian V Jones
Journal:  Bioeng Bugs       Date:  2012-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.